| Date | Title | Description |
| 31.10.2025 | Названы самые перспективные стартапы мира. «Инк» узнал что они создают | Всему миру известны компании, некоторые из которых стартовали из гаража или студенческой комнаты. С развитием искусственного интеллекта тысячи стартапов регулярно борются за место под солнцем (и за инвестиции). Одна из возможностей получить... |
| 29.05.2025 | AI meets Health: 10 promising European startups leading the change in 2025 | Europe’s healthcare landscape is undergoing a quiet revolution, powered not just by new medicines but by lines of code. Artificial Intelligence is swiftly becoming the doctor’s most powerful ally, enhancing diagnostics, streamlining workflo... |
| 03.12.2024 | Paris-based Orakl Oncology raises €11 million to launch AI-powered drug development tools | Orakl Oncology, a French oncology startup focused on cancer drug development, has secured €11 million in seed funding.
The round was led by Singular with participation from Bpifrance, including the Grand Prix i Lab, and existing investors. ... |
| 03.12.2024 | Orakl Oncology raises €11M to launch AI-powered drug development products | Orakl Oncology, a precision oncology company, has raised €11M seed funding round led by Singular, with support from Bpifrance including the Grand Prix i-Lab, and participation from existing investors.
This capital will be used to accelerate... |
| 03.12.2024 | Orakl Oncology Raises €11M in Seed Funding | Orakl Oncology, a Paris, France-based precision oncology company, raised €11M in Seed funding.
The round was led by Singular, with participation from Bpifrance including the Grand Prix i-Lab, and existing investors.
Founded in 2023 by Fanny... |
| 04.10.2023 | Orakl Oncology Raises €3M in Funding | Orakl Oncology, a Paris, France-based precision oncology startup, raised €3M in funding.
The round was led by Speedinvest with additional investment from HCVC and Verve Ventures.
Orakl Oncology is combining cell biology, engineering and mac... |
| 04.10.2023 | Orakl Oncology bag €3M to propel techbio platform for accelerated cancer drug development | Read this article in:
France-based Orakl Oncology, a precision oncology drug discovery start-up, announced that it has raised €3M to develop its techbio platform. The company claims the platform integrates biology and real-world patient dat... |
| - | Orakl Oncology | “Cultivated with love by the Orakl team.” |
